Analystreport

Ascendis Pharma A/S (NASDAQ: ASND) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $161.00 price target

Ascendis Pharma A/S - American Depositary Shares  (ASND) 
Last ascendis pharma a/s - american depositary shares earnings: 11/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ascendispharma.com